Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyse the changes of A-H premium on 196 stocks over the last week. The average A-H premium was 81.7% as of Aug 7th.</li>
<li>The average A-H premium changed by 0.8ppt week-on-week, led by communication services, health care, utilities and offset by consumer staples, materials.</li>
<li>We highlight weekly changes in A-H premium for Remegen, Cmoc, Shandong Gold Mining Co Lt-H, Luxshare Ict, Beone Medicines.</li>
</ul>


We analyse the changes of A-H premium on 196 stocks over the last week. The average A-H premium was 81.7% as of Aug 7th.
The average A-H premium changed by 0.8ppt week-on-week, led by communication services, health care, utilities and offset by consumer staples, materials.
We highlight weekly changes in A-H premium for Remegen, Cmoc, Shandong Gold Mining Co Lt-H, Luxshare Ict, Beone Medicines.


A-H Premium Weekly (Aug 7th): Remegen, Cmoc, Shandong Gold Mining Co Lt-H, Luxshare Ict

Equity Capital Markets

Luxvisions Innovation Technology / Equity Capital Markets

Luxvisions Innovation Technology (1853852D HK)

<ul>
<li>Luxvisions Innovation, a camera module and precision optical solutions supplier, has filed its prospectus with the HKEX. CITIC and CICC are the joint sponsors.</li>
<li>We look at the company's core segments: consumer electronics and smart office applications.</li>
<li>We then look at the company's financial profile, profit growth, pre-IPO valuation and investor backing.</li>
</ul>


Luxvisions Innovation, a camera module and precision optical solutions supplier, has filed its prospectus with the HKEX. CITIC and CICC are the joint sponsors.
We look at the company's core segments: consumer electronics and smart office applications.
We then look at the company's financial profile, profit growth, pre-IPO valuation and investor backing.


Luxvisions Innovation (立景创新) Pre-IPO: Tearsheet

<ul>
<li>XREAL, an AR eyewear maker, has filed its prospectus with the HKEX. CICC and Citi are the joint sponsors.</li>
<li>We look at the company's core segments: AR eyewear and accessories.</li>
<li>We put XREAL on Watch. Market leadership and named partners are positives, but cash burn, breakeven risk and product cycles matter.</li>
</ul>


XREAL, an AR eyewear maker, has filed its prospectus with the HKEX. CICC and Citi are the joint sponsors.
We look at the company's core segments: AR eyewear and accessories.
We put XREAL on Watch. Market leadership and named partners are positives, but cash burn, breakeven risk and product cycles matter.


Zhongji InnoLight / Equity Capital Markets

<ul>
<li>Zhongji Innolight raised HKD 52,891m (USD 6,746m) from its global offering and will list on the HKEx on Thursday, July 30, 2026.</li>
<li>In our previous notes, we looked at the company's fundamentals and the deal terms.</li>
<li>In this note, we provide an update for the IPO before its trading debut.</li>
</ul>


Zhongji Innolight raised HKD 52,891m (USD 6,746m) from its global offering and will list on the HKEx on Thursday, July 30, 2026.
In our previous notes, we looked at the company's fundamentals and the deal terms.
In this note, we provide an update for the IPO before its trading debut.


Zhongji Innolight (中际旭创) IPO Trading

<ul>
<li>Zhongji Innolight, a global supplier of optical transceivers, launched its IPO to raise USD 7,021m through an A+H listing. GS, CICC, MS, and GF are the deal sponsors.</li>
<li>In this note, we look at the deal terms and provide our thoughts on valuation for the company.</li>
<li>We analyze reference A+H transactions, cornerstone and sponsor performance and assess the risk-reward of the deal.</li>
</ul>


Zhongji Innolight, a global supplier of optical transceivers, launched its IPO to raise USD 7,021m through an A+H listing. GS, CICC, MS, and GF are the deal sponsors.
In this note, we look at the deal terms and provide our thoughts on valuation for the company.
We analyze reference A+H transactions, cornerstone and sponsor performance and assess the risk-reward of the deal.


Zhongji Innolight (中际旭创) A+H IPO: Analysis of Deal Terms

China

Luxshare Precision Industry Co., Ltd. researches, manufactures and sells connectors. The Company's products are widely used in computers, communication devices, consumer electronics products and automobiles.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Luxshare Precision Industry (002475 CH)

A-H Premium Weekly (Aug 7th): Remegen, Cmoc, Shandong Gold Mining Co Lt-H, Luxshare Ict

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Remegen, Cmoc, Shandong Gold Mining Co Lt-H, Luxshare Ict,...

Ke Yan, CFA, FRM

Luxvisions Innovation (立景创新) Pre-IPO: Tearsheet

Luxvisions Innovation has filed its prospectus with the HKEX. We look at the company's business and operating profile, its industry backdrop, its...

Ke Yan, CFA, FRM

XREAL Pre-IPO: Early Thoughts

XREAL has filed its prospectus with the HKEX. We look at its business, industry, financials, peer valuation and shareholders, and whether the deal...

Ke Yan, CFA, FRM

Zhongji Innolight (中际旭创) IPO Trading

Zhongji Innolight raised USD 6,746m to list on HKEX on Thursday, July 30. We are cautious on debut performance given the A-share's fall since...

Ke Yan, CFA, FRM

Zhongji Innolight (中际旭创) A+H IPO: Analysis of Deal Terms

We analyze Zhongji Innolight's USD 7,021m Hong Kong IPO. We look at deal terms, track records of cornerstone investors and sponsors, as well as its...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)